Department of Trauma/Surgical Critical Care, The Medical Center Navicent Health and School of Medicine, 5225Mercer University, Macon, GA, USA.
School of Medicine, 5225Mercer University, Macon, GA, USA.
Am Surg. 2022 Sep;88(9):2115-2118. doi: 10.1177/00031348221091940. Epub 2022 Apr 29.
The coronavirus disease 2019 (COVID-19) global pandemic has impacted daily life and medical practices around the world. Hospitals are continually making observations about this unique population as it relates to laboratory data and outcomes. Plasma D-dimer levels have been shown to be promising as a prognostic factor for outcomes in COVID-19 patients. This single institution retrospective study investigates the correlation between D-dimer and patient outcomes in our inpatient COVID-19 patient population.
COVID-19 confirmed positive patients who were admitted between March 2020 and May 2020 at our hospital were identified. Admission and peak D-dimer values and patient outcomes, including intubation and mortality, were retrospectively analyzed.
Ninety-seven patients met criteria for inclusion in the study Mean age was 63.2 years, median admission D-dimer 2.35ug/mL, and median peak D-dimer 2.74ug/mL. Average time to peak D-dimer was 3.2 days. Patient's requiring intubation had higher admission D-dimers (3.79ug/mL vs. 1.62 ug/mL).
Higher admission and peak D-dimer values were associated with worsening clinical outcomes, specifically with higher rates of intubation and mortality. Noting D-dimer trends early in a patients' COVID course, regardless of patients' clinical condition, may allow opportunities for physicians to provide early intervention to prevent these outcomes.
2019 年冠状病毒病(COVID-19)全球大流行影响了全世界的日常生活和医疗实践。医院不断观察这一独特人群与实验室数据和结果的关系。血浆 D-二聚体水平已被证明是 COVID-19 患者预后的一个有前途的预测因素。这项单中心回顾性研究调查了我们住院 COVID-19 患者人群中 D-二聚体与患者结局之间的相关性。
确定了我们医院在 2020 年 3 月至 2020 年 5 月期间收治的 COVID-19 确诊阳性患者。回顾性分析了入院时和峰值 D-二聚体值以及患者结局,包括插管和死亡率。
97 名患者符合纳入研究标准。平均年龄为 63.2 岁,中位入院 D-二聚体 2.35ug/mL,中位峰值 D-二聚体 2.74ug/mL。达到峰值 D-二聚体的平均时间为 3.2 天。需要插管的患者入院 D-二聚体值较高(3.79ug/mL 比 1.62ug/mL)。
较高的入院和峰值 D-二聚体值与临床结局恶化相关,特别是与插管和死亡率较高相关。无论患者的临床状况如何,在患者 COVID 病程早期注意 D-二聚体趋势,可能为医生提供早期干预机会,以预防这些结局。